Skip to content

Temporal variation of propoofol dosage in painless gastrointestinal endoscopy

Temporal variation of propoofol dosage in painless gastrointestinal endoscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093328
Enrollment
Unknown
Registered
2024-12-03
Start date
2024-12-03
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

Group1:8:00-10:00:none
Group 2:10:00-12:00:none
Group 3:13:00-15:00:none
Group 4:15:00-17:00:none

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: adult patients (18–65 years) with an American Society of Anesthesiologists (ASA) classification of I or II, underwent diagnostic esophagogastroduodenoscopy and colonoscopy under general anesthesia without intubation

Exclusion criteria

Exclusion criteria: documented allergic reaction to propofol or opioids, history of opioids or propofol misuse, administration of general anesthesia within the preceding 30 days, the necessity for therapeutic procedures during GI, anesthesia duration exceeding 60 minutes, incomplete colonoscopy due to inadequate bowel preparation, and unwillingness to participate in the research.

Design outcomes

Primary

MeasureTime frame
Propofol dosage;

Secondary

MeasureTime frame
perioperative blood pressure;perioperative heart rate;perioperative SpO2;perioperative BIS;

Countries

China

Contacts

Public ContactQiong Lan

Peking University Third Hospital

13810146245@163.com+86 10 8226 7260

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026